BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33257031)

  • 1. Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.
    Shi Z; Platz EA; Wei J; Na R; Fantus RJ; Wang CH; Eggener SE; Hulick PJ; Duggan D; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; Xu J
    Eur Urol; 2021 Mar; 79(3):419-426. PubMed ID: 33257031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National economic and development indicators and international variation in prostate cancer incidence and mortality: an ecological analysis.
    Neupane S; Bray F; Auvinen A
    World J Urol; 2017 Jun; 35(6):851-858. PubMed ID: 27744614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-Head Comparison of Family History of Colorectal Cancer and a Genetic Risk Score for Colorectal Cancer Risk Stratification.
    Weigl K; Hsu L; Knebel P; Hoffmeister M; Timofeeva M; Farrington S; Dunlop M; Brenner H
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00106. PubMed ID: 31800541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited Mutations in Men Undergoing Multigene Panel Testing for Prostate Cancer: Emerging Implications for Personalized Prostate Cancer Genetic Evaluation.
    Giri VN; Obeid E; Gross L; Bealin L; Hyatt C; Hegarty SE; Montgomery S; Forman A; Bingler R; Kelly WK; Dicker AP; Winheld S; Trabulsi EJ; Chen DYT; Lallas CD; Allen BA; Daly MB; Gomella LG
    JCO Precis Oncol; 2017 May; 1():. PubMed ID: 34164591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Lifestyle and Genetic Risks with Obesity and Related Chronic Diseases in the UK Biobank: A Prospective Cohort Study.
    Zhang Y; Li Y; Peila R; Wang T; Xue X; Kaplan RC; Dannenberg AJ; Qi Q; Rohan TE
    Am J Clin Nutr; 2024 Apr; ():. PubMed ID: 38677521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men.
    Turner AR; Lane BR; Rogers D; Lipkus I; Weaver K; Danhauer SC; Zhang Z; Hsu FC; Noyes SL; Adams T; Toriello H; Monroe T; McKanna T; Young T; Rodarmer R; Kahnoski RJ; Tourojman M; Kader AK; Zheng SL; Baer W; Xu J
    Cancer; 2016 Nov; 122(22):3564-3575. PubMed ID: 27433786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Prevention of Prostate Cancer.
    Gandaglia G; Leni R; Bray F; Fleshner N; Freedland SJ; Kibel A; Stattin P; Van Poppel H; La Vecchia C
    Eur Urol Oncol; 2021 Dec; 4(6):877-892. PubMed ID: 34716119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The added value of genetic information in colorectal cancer risk prediction models: development and evaluation in the UK Biobank prospective cohort study.
    Smith T; Gunter MJ; Tzoulaki I; Muller DC
    Br J Cancer; 2018 Oct; 119(8):1036-1039. PubMed ID: 30323197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a prostate cancer polygenic risk score.
    Black MH; Li S; LaDuca H; Lo MT; Chen J; Hoiness R; Gutierrez S; Tippin-Davis B; Lu HM; Gielzak M; Wiley K; Shi Z; Wei J; Zheng SL; Helfand BT; Isaacs W; Xu J
    Prostate; 2020 Nov; 80(15):1314-1321. PubMed ID: 33258481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Cancer Progression and the Epigenome.
    Arap W; Pasqualini R; Costello JF
    N Engl J Med; 2020 Dec; 383(23):2287-2290. PubMed ID: 33264551
    [No Abstract]   [Full Text] [Related]  

  • 11. Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.
    Shi Z; Wei J; Na R; Resurreccion WK; Zheng SL; Hulick PJ; Helfand BT; Talamonti MS; Xu J
    Int J Cancer; 2021 Apr; 148(7):1658-1664. PubMed ID: 33300603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT-based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration-naïve oligometastatic prostate cancer.
    Sheikhbahaei S; Reyes DK; Rowe SP; Pienta KJ
    Prostate; 2021 Feb; 81(2):127-134. PubMed ID: 33259087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapies for Clinically Localized Prostate Cancer: A Comparative Effectiveness Review.
    Wilt TJ; Ullman KE; Linskens EJ; MacDonald R; Brasure M; Ester E; Nelson VA; Saha J; Sultan S; Dahm P
    J Urol; 2021 Apr; 205(4):967-976. PubMed ID: 33350857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Other and All-Cause Mortality among Men Diagnosed with Prostate Cancer in the PLCO Trial.
    Pierre-Victor D; Pinsky PF; Miller E; Parnes H
    J Urol; 2021 May; 205(5):1372-1378. PubMed ID: 33350321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics and spatial distributions of prostate cancer in autopsy specimens.
    Zhou Y; Mai Z; Yan W; Chen Y; Zhou Z; Xiao Y; Wang W; Shang Z; Yuan R; Ji Z; Li H
    Prostate; 2021 Feb; 81(2):135-141. PubMed ID: 33306857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Delay and Pathological Outcomes for Clinically Localized High-Risk Prostate Cancer.
    Xia L; Talwar R; Chelluri RR; Guzzo TJ; Lee DJ
    JAMA Netw Open; 2020 Dec; 3(12):e2028320. PubMed ID: 33289846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis.
    Spratt DE; Malone S; Roy S; Grimes S; Eapen L; Morgan SC; Malone J; Craig J; Dess RT; Jackson WC; Hartman HE; Kishan AU; Mehra R; Kaffenberger S; Morgan TM; Reichert ZR; Alumkal JJ; Michalski J; Lee WR; Pisansky TM; Feng FY; Shipley W; Sandler HM; Schipper MJ; Roach M; Sun Y; Lawton CAF
    J Clin Oncol; 2021 Jan; 39(2):136-144. PubMed ID: 33275486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma.
    Tsai LL; Bhatt RS; Strob MF; Jegede OA; Sun MRM; Alsop DC; Catalano P; McDermott D; Robson PM; Atkins MB; Pedrosa I
    Radiology; 2021 Feb; 298(2):332-340. PubMed ID: 33258745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of radiation dose on recurrence in high-risk prostate cancer patients.
    Deek M; Lilleby W; Vaage V; Hole KH; DeWeese T; Stensvold A; Tran P; Seierstad T
    Prostate; 2020 Nov; 80(15):1322-1327. PubMed ID: 33258482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment.
    McMahon S; Basak R; Zhou X; Smith AB; Song L; Pruthi RS; Wallen EM; Nielsen ME; Tan HJ
    Urology; 2021 Mar; 149():103-109. PubMed ID: 33352164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.